# A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of DESF in Pediatric Subjects

> **NCT07703982** · PHASE1 · COMPLETED · sponsor: **Aquestive Therapeutics** · enrollment: 32 (actual)

## Conditions studied

- Allergic Reaction

## Interventions

- **DRUG:** DESF

## Key facts

- **NCT ID:** NCT07703982
- **Lead sponsor:** Aquestive Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-26
- **Primary completion:** 2025-03-14
- **Final completion:** 2025-05-21
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07703982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07703982, "A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of DESF in Pediatric Subjects". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07703982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*